These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15191068)

  • 1. Keys to unlocking the mysteries of rheumatic autoimmune disease.
    Moser KL; Gaffney P; Peterson E; Behrens T
    Minn Med; 2004 May; 87(5):46-51. PubMed ID: 15191068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool.
    Centola M; Frank MB; Bolstad AI; Alex P; Szanto A; Zeher M; Hjelmervik TO; Jonsson R; Nakken B; Szegedi G; Szodoray P
    Scand J Immunol; 2006 Sep; 64(3):236-42. PubMed ID: 16918692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are pediatric autoimmune diseases primarily genetic diseases?
    Shaw EA; Stevens AM
    Curr Opin Rheumatol; 2008 Sep; 20(5):589-94. PubMed ID: 18698183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of complex autoimmune diseases: non-MHC susceptibility genes.
    Wandstrat A; Wakeland E
    Nat Immunol; 2001 Sep; 2(9):802-9. PubMed ID: 11526390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.
    Diamond B; Bluestone J; Wofsy D
    Arthritis Rheum; 2001 Aug; 44(8):1730-5. PubMed ID: 11508422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies using functional genomics in rheumatic diseases.
    Burmester GR; Häupl T
    Autoimmun Rev; 2004 Nov; 3(7-8):541-9. PubMed ID: 15546803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of susceptibility genes to rheumatic diseases].
    Tsuchiya N; Tokunaga K
    Nihon Rinsho; 1999 Feb; 57(2):323-8. PubMed ID: 10077998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
    Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA genes and predisposition to rheumatic diseases.
    Arnett FC
    Hosp Pract (Off Ed); 1986 Dec; 21(12):89-100. PubMed ID: 3098761
    [No Abstract]   [Full Text] [Related]  

  • 10. Shared familial aggregation of susceptibility to autoimmune diseases.
    Hemminki K; Li X; Sundquist K; Sundquist J
    Arthritis Rheum; 2009 Sep; 60(9):2845-7. PubMed ID: 19714648
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histocompatibility HLA system in man. Considerations in the light of current concept. Part III. The relationship between HLA antigens and disease susceptibility].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(7-8):814-7. PubMed ID: 11769393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared symptoms in rheumatic diseases: a blessing or a curse?
    Huizinga TW; Gröndal G
    Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity?
    Brand O; Gough S; Heward J
    Expert Rev Mol Med; 2005 Oct; 7(23):1-15. PubMed ID: 16229750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling in human autoimmunity.
    Baechler EC; Batliwalla FM; Reed AM; Peterson EJ; Gaffney PM; Moser KL; Gregersen PK; Behrens TW
    Immunol Rev; 2006 Apr; 210():120-37. PubMed ID: 16623768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA antigens and rheumatic diseases].
    Timofeev VT
    Vopr Revm; 1982; (4):53-64. PubMed ID: 6760543
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.
    Camargo JF; Correa PA; Castiblanco J; Anaya JM
    Genes Immun; 2004 Dec; 5(8):609-14. PubMed ID: 15470475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological therapies in autoimmune chronic inflammatory diseases (ACIDs).
    Ferraccioli GF; Gremese E
    Eur Rev Med Pharmacol Sci; 2006; 10(1):37-40. PubMed ID: 16494110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon signature in autoimmune diseases.
    Rönnblom L; Eloranta ML
    Curr Opin Rheumatol; 2013 Mar; 25(2):248-53. PubMed ID: 23249830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.